Stock 2QG QUANTUM GENOMICS
Add to a list
To use this feature you must be a member
Log inSign up

All News Quantum Genomics Deutsche Boerse AG

Equities

2QG

FR0011648971

Market Closed - Deutsche Boerse AG
Other stock markets
 03:17:48 2024-05-02 am EDT 		5-day change 1st Jan Change
0.115 EUR +4.55% Intraday chart for Quantum Genomics +19.54% +30.68%
Mar. 13 Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Quantum Genomics : Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure’s securities.
AT
Quantum Genomics : Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24.
AT
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Quantum Genomics : Quantum Genomics enters into exclusive negotiations with ExactCure
AT
Quantum Genomics : Quantum Genomics Releases First-Half 2023 Financial Results
AT
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Quantum Genomics: negotiations with Vistacare terminated
CF
Quantum Genomics : Quantum Genomics announces resuming discussions with HealthTech companies following the termination of exclusive negotiations with Vistacare Medical
AT
Quantum Genomics : Quantum Genomics enters into exclusive negotiations with Vistacare Medical with the ambition of creating a reference player in the management of complex wounds
AT
Global markets live: Microsoft, Raytheon, JPMorgan, Credit Suisse...
Our Logo
Quantum Genomics : Quantum Genomics releases its 2022 financial results and provides an update on its MandA discussions
AT
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Quantum Genomics: advanced discussions with a partner
CF
Quantum Genomics Ousts Board President; CEO Named Successor
MT
Quantum Genomics : Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects
AT
Quantum Genomics : Quantum Genomics gives an update
AT
Quantum Genomics' Hypertension Drug Firibastat Fails to Show Significant Efficacy in Late-Stage Trial
MT
Quantum Genomics : Quantum Genomics announces lack of significant efficacy for firibastat in their phase III study, FRESH and is redirecting to new developments
AT
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments
AQ
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, Fresh and Is Redirecting to New Developments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALQGC Stock
  4. 2QG Stock
  5. News Quantum Genomics